Ergoteles LLC Aeglea Bio Therapeutics, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.35 - $1.54 $5,152 - $22,671	14,722 New	14,722 $6,000
Q2 2022 Aug 12, 2022	BUY	$0.5 - $2.66 $73,600 - $391,552	147,200 New	147,200 $74,000
Q3 2021 Nov 15, 2021	SELL	$6.03 - $7.95 $205,623 - $271,095	-34,100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$6.32 - $8.38 $215,512 - $285,758	34,100 New	34,100 $237,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.